Have you progressed on Zelboraf or Dabrafenib?
- This topic is empty.
Viewing 1 post (of 1 total)
-
Posts
-
A new Phase II clinical trial just opened up for people who have progressed on a BRAF inhibitor. Several sites on the East coast and Tennnessee. Clinical Trial Identifier: NCT01519427
Selumetinib and Akt Inhibitor MK2206 in Treating Patients With Stage III or Stage IV Melanoma Who Failed Prior Therapy With Vemurafenib or Dabrafenib
Viewing 1 post (of 1 total)
- The forum ‘Melanoma: Stage III’ is closed to new topics and replies.